AbbVie Inc.
Venclexta
Oncology
Indications and Usage
1.1 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
VENCLEXTA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
1.2 Acute Myeloid Leukemia
VENCLEXTA is indicated in combination with azacitidine, or decitabine, or low-dose cytarabine for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.
More than 200,000 clinicians have integrated PrescriberPoint into their clinical workflows
HOW IT WORKS
The easy way to access samples
Create Free AccountRequest, track, and manage samples from multiple brands
Connect with a RepHave access to pharma representatives in one place to request your samples
Get your SampleManage your reps and samples in one place
WHO IS PRESCRIBERPOINT
Increasing patient access to medications they need
At PrescriberPoint, we're revolutionizing how healthcare providers get patients the medications they need. We craft solutions that help providers address the challenges in patient access and improve outcomes.200K+Visitors Each Month
100K+Engagements Each Month
1M+Resources Viewed
WHAT HCPS ARE SAYING
FAQs
All you need to know to order samples
Do you ship internationally?
Currently, PrescriberPoint is available only in the U.S, but we are excited to expand our reach in the future! Stay connected by following us or signing up for our newsletter to get the latest updates, including announcements about new market launches.
How long does an order take to ship?
What is your stance on data privacy?